Transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care
blog

5 Tips to Help Workers’ Comp Payers Optimize IT Resources

The insurance sector is experiencing an IT talent shortage. How can workers’ comp payers optimize the IT resources they already have?
Read More
rxinformer

Things Change: The Growing Diversity of Pharmacy Cost Drivers

Smaller, more niche drug trends across different populations and geographies
Read More
INDUSTRY SURVEY

2023 Industry Insights Survey Report

We surveyed 500+ workers’ comp professionals on the biggest industry disruptors and priorities
Read More

Featured Videos

Personalize my experience

Make selections below to see articles and information related to your role and interests.
  • I am a

  • I'm interested in

Novel Migraine Agents: What Is Their Place in Injured Worker Therapy?

Novel migraine agents are continuing to enter the market, providing alternative forms of pain relief for migraine sufferers. What are the efficacy and cost considerations for injured workers?

Mar 2024

FDA Evaluates Report of Suicidal Thoughts with GLP-1 Inhibitors

While no clear link is established to these obesity and diabetes drugs, the FDA will continue to monitor data.

Feb 2024

2024 Workers’ Comp Industry Insights Survey Report

This sixth annual survey report highlights the top challenges and priorities of 500 industry professionals.

Feb 2024

U.S. Department of Labor Issues Final Rule on Worker Classification

The rule clarifies differences between employees and contractors, establishing who is entitled to benefits – including workers’ comp.

Feb 2024

Ten Psychedelic Bills Introduced Across State Legislatures

States so far include Alaska, Arizona, California, Hawaii, Indiana, Illinois, Massachusetts, Maryland, New Jersey, and Wisconsin.

Feb 2024

FDA Approves First Test to Help Identify Risks of Developing Opioid Use Disorder

The AvertD test is intended to be used prior to first exposure to oral opioids in patients considered for a 4-30 day prescription for acute pain.

Feb 2024

Department of Health and Human Services Reveals Cannabis Rescheduling Findings

With many federal agencies in alignment, the ultimate decision rests with the DEA.

Feb 2024

FDA Issues Respective Warnings for Compounded and Counterfeit Semaglutide

The growing demand for this drug has led individuals to search for semaglutide from alternative sources.

Jan 2024

The Mind-Body Connection: Exploring the Relationship Between Injury and Mental Health

Injuries accompanied by mental health disorders can increase claim costs and delay recovery.

Jan 2024

Growing Shifts in Child Labor Laws

Many states passed or proposed changes in 2023, with two states so far working on bills for 2024.

Jan 2024

White House Pardons Simple Possession Charges for Marijuana

A recent proclamation applies to simple federal possession charges on or before December 22, 2023.

Jan 2024

PTSD Presumptions Could See More Action in 2024

As legislative sessions open, several states have continued to introduce PTSD bills.

Jan 2024

Emerging/Current Medical and Drug Trends

Healthe’s VP of Clinical Services, Silvia Sacalis, will co-present at the 20th Annual Workers’ Compensation Insurance ExecuSummit.

Jan 2024

This Year’s Top Insights in Workers’ Compensation Medical Management

As we enter 2024, let’s look at the top insights for workers’ comp managed care programs in 2023.

Jan 2024

FDA Warns of Rare Drug Interactions with Antiseizure Drugs

Hypersensitivity reactions may start as a rash but can quickly result in injury to internal organs.

Dec 2023

Beyond Opioids: Drugs of Concern in Workers’ Compensation

As opioid utilization decreases, other pharmacy trends bear watching.

Dec 2023

Comorbidities and Recovery After Physical Therapy for Low Back Pain

A new WCRI report utilizes data from 68,850 workers from 2017-2021.

Dec 2023

Bureau of Labor Statistics Reports on Workplace Injuries and Illnesses

Employers reported 2.8 million nonfatal workplace injuries and illnesses in 2022, an increase of 7.5% from 2021.

Dec 2023

White House Issues Executive Order on Artificial Intelligence

The order seeks increased transparency from AI companies regarding model operations, safety and privacy standards, and consumer/worker protections.

Dec 2023

Industry Wide Trends & Pharmacy Trends

Healthe expertise is featured in Risk & Insurance magazine, both on larger industry trends, and on evolving drug trends.

Dec 2023

FDA Approves New Formulation of Combogesic

The acetaminophen and ibuprofen combination was approved for IV use, and as an adjunct to opioid therapy for the treatment of pain.

Nov 2023

What Do I Need to Know About DME Trends?

A Healthesystems clinical expert tackles questions about Durable Medical Equipment (DME) trends.

Nov 2023

CDC Reports on Mental Health Struggles Amongst Healthcare Workers

Approximately 45.6% of health workers reported feeling burnout often or very often in 2022.

Nov 2023

California Bans Pre-Employment Marijuana Screening

Similar to a Washington law passed earlier this year, employees are not permitted to possess, to be impaired by, or to use cannabis on the job.

Nov 2023

FDA Warns of Risks with Compounded Ketamine Products

The ketamine molecule is not FDA-approved in any formulation for the treatment of psychiatric disorders.

Nov 2023

Healthe Leaders in the Media

Tate Rice and Silvia Sacalis share their respective expertise on key issues in physical therapy and pharmacy management.

Nov 2023

7 Potential Applications for Artificial Intelligence in Workers’ Comp Medical Programs

AI technology is advancing rapidly, with new applications being discovered every day for the medical aspects of claims and workers’ compensation claims management.

Oct 2023

3 Ways the Digital Experience Can Drive Meaningful Engagement for Injured Workers

Using technology such as mobile apps, we can help injured workers navigate the daunting workers’ comp system.

Oct 2023

New Depression Product and Diabetes Generic Approvals

Exuua was approved for major depressive disorder, while two diabetes medications receive generic approvals.

Oct 2023

The Real Promise of Artificial Intelligence in Healthcare and Workers’ Comp

Potential applications, benefits, pitfalls, questions, and the matter of regulation.

Oct 2023

1 2 3 4 5 15 16 17 18 19
lockenvelopephone-handsetmagnifiermenuarrow-rightcross-circle